Letter: Physicians defend use of antipsychotics in nursing homes

Share this article:

Geriatric psychiatrists are defending the use of antipsychotics given to nursing home residents with dementia following a series of Boston Globe articles about the over-prescribing of such medications.

In a letter to the editor, two members of the Massachusetts Psychiatric Society assert that while non-drug behavioral interventions should be used foremost in treating agitation and aggression in dementia residents, the use of off-label medications is a “medically accepted treatment approach,” according to David Harnett, M.D., and James Ellison, M.D.

The “demonization of anti-psychotics may limit treatment options and discourage nursing homes from accepting behaviorally difficult patients. These institutions deserve our support, not condemnation,” they wrote.

Hartnett and Ellison were responding to a package of Boston Globe articles that examined the amount of facilities that use antipsychotics more than is federally recommended.

Click here to read the full letter.

Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.